PlainRecalls
FDA Drug Moderate Class II Completed

Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 160 mg, 90 tablets Rx Only Manufactured for: Camber Pharmaceuticals, Inc. Piscataway NJ 08854 By: Hetero Hetero Labs Limited, Unit V, Pollepally Jadcherla Mahabubnagar - 509-301, India. NDC 31722-747-90 UPC 331722747905

Reported: August 29, 2018 Initiated: August 8, 2018 #D-1115-2018

Product Description

Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 160 mg, 90 tablets Rx Only Manufactured for: Camber Pharmaceuticals, Inc. Piscataway NJ 08854 By: Hetero Hetero Labs Limited, Unit V, Pollepally Jadcherla Mahabubnagar - 509-301, India. NDC 31722-747-90 UPC 331722747905

Reason for Recall

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Details

Units Affected
441,408 bottles
Distribution
Nationwide
Location
Jadcherla Mandal, Mahaboob Nagar

Frequently Asked Questions

What product was recalled?
Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 160 mg, 90 tablets Rx Only Manufactured for: Camber Pharmaceuticals, Inc. Piscataway NJ 08854 By: Hetero Hetero Labs Limited, Unit V, Pollepally Jadcherla Mahabubnagar - 509-301, India. NDC 31722-747-90 UPC 331722747905. Recalled by Hetero Labs Limited Unit V. Units affected: 441,408 bottles.
Why was this product recalled?
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 29, 2018. Severity: Moderate. Recall number: D-1115-2018.